Skip to main content
Premium Trial:

Request an Annual Quote

Vincent Kazmer, Eric Neumann, Michael Lytton, Gerhard Laur, Stefan Ryser


Vincent Kazmer, formerly executive vice president and chief financial officer of NetGenics, has joined Phase-1 Molecular Toxicology of Santa Fe, N.M., as chief executive officer.

Prior to NetGenics, Kazmer was president, chief executive officer, and director of Lark Technologies, a molecular biology contract research organization; a co-founder and president of Copernicus Gene Systems Inc., a private gene therapy company; senior vice president of United States Biochemical; and a co-founder and vice president of Ribozyme Pharmaceuticals.

Eric Neumann has resigned from his post as vice president of life science informatics at 3rd Millennium of Cambridge, Mass. He will remain in the Boston area where he will work as an independent consultant.

Genaissance Pharmaceuticals of New Haven, Conn., has appointed Michael Lytton, general partner at Oxford Bioscience Partners, to its board of directors. Gerhard Laur, head of merchant banking at A&A Actienbank and Stefan Ryser, managing director of Bear Stearns Health Innoventures, are leaving the board, which now numbers seven.

Filed under

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.